electronRx to launch purpleDx pulmonary disease smartphone app for remote lung function monitoring

electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical device standards, at CES 2025 from 7-10 Jan in Las Vegas, USA.

Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Researchers examine how the COVID-19 pandemic affected cancer diagnosis rates between 2021 and 2020.

September 13, 2024

Key congressman blasts HHS for lack of cooperation on Covid-19

The Health and Human Services Department’s lack of cooperation with a congressional committee investigating the Covid-19 pandemic is “unacceptable” and could prompt the committee to

February 16, 2024

Once one of immuno-oncology’s next great hopes, CD47 faces final shots on goal

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.